The Special Investigation Team (SIT) probing Sunanda's case questioned Singh and Bajrangi twice in the past three days. The SIT also questioned around a dozen chemists in and around Tharoor's bungalow in Lodhi Estate, a police source said today.
"They were all questioned in light of the information emerging out of the AIIMS medical board's opinion on the FBI report in connction with the case," said the source, adding that the questions revolved around the source of drugs suspected to have caused 51-year-old Sunanda's death.
Tharoor was not subjected to the test but was questioned thrice in the case.
The AIIMS medical board, which gave its opinion on the FBI report on Sunanda's viscera and other samples, had unanimously concluded that she died of poisoning, with the presence of Alprax in her stomach.
The board did not rule out the possibility of any injectable poison, in view of a particular mark on Sunanda's body, and said that the FBI report confirmed the presence of lidocaine in her body.
It also said that the Special Investigation team (SIT) probing the case should "thoroughly investigate" if any person had access to injectable agents in view of a syringe mark spotted in Sunanda's body.
In January last year, Delhi Police had registered a case of murder in connection with the death of Sunanda. An AIIMS medical board had found poisoning as reason for her death following which the police had sent her viscera samples to an FBI lab in US.
As police could not firm up about cause of the death based on the FBI report, they requested a medical board of AIIMS to analyse the contents of the report.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
